-
[
Mol Genet Metab,
2007]
3-Hydroxy-3-methylglutaryl-CoA lyase (HL) deficiency is a rare autosomal recessive genetic disorder that affects ketogenesis and l-leucine catabolism, which generally appears during the first year of life. Patients with HL deficiency have a reduced capacity to synthesize ketone bodies. The disease is caused by lethal mutations in the HL gene (HMGCL). To date, up to 30 variant alleles (28 mutations and 2 SNPs) in 93 patients have been reported, with a recognizable population-specific mutational spectrum. This disorder is frequent in Saudi Arabia and the Iberian Peninsula (Portugal and Spain), where two mutations (122G>A and 109G>A) have been identified in 87% and 94% of the cases, respectively. In most countries a few patients have a high level of allelic heterogeneity. The mutations are distributed along the gene sequences, although some clustering was observed in exon 2, conforming a possible hot spot. Recently, the crystal structures of the human and two bacterial HL have been published. These experimentally obtained structures confirmed the overall architecture, previously predicted by our group and others using bioinformatic approaches, which shows the (betaalpha)8-barrel structure of the enzyme. In addition, the crystals confirmed the presence of an additional COOH domain containing important structures and residues for enzyme functionality and oligomerization processes. Here, we review all HMGCL mis-sense mutations identified to date, and their implication in enzyme structure and function is discussed. We found that genotype-phenotype correlations are difficult to establish because the evolution of the disease seems more related to the causes of hypoglycaemia (fasting or acute illness) than to a particular genotype.
-
[
WormBook,
2005]
Evolutionary innovation requires genetic raw materials upon which selection can act. The duplication of genes is of fundamental importance in providing such raw materials. Gene duplications are very widespread in C. elegans and appear to arise more frequently than in either Drosophila or yeast. It has been proposed that the rate of duplication of a gene is of the same order of magnitude as the rate of mutation per nucleotide site, emphasising the enormous potential that gene duplication has for generating substrates for evolutionary change. The fate of duplicated genes is discussed. Complete functional redundancy seems unstable in the long term. Most models require that equality amongst duplicated genes must be disrupted if they are to be preserved. There are various ways of achieving inequality, involving either the nonfunctionalization of one copy, or one copy acquiring some novel, beneficial function, or both copies becoming partially compromised so that both copies are required to provide the overall function that was previously provided by the single ancestral gene. Examples of C. elegans gene duplications that appear to have followed each of these pathways are considered.
-
[
Parasitology,
1999]
The initiation of genome projects on helminths of medical importance promises to yield new drug targets and vaccine candidates in unprecedented numbers. In order to exploit this emerging data it is essential that the user community is aware of the scope and quality of data available, and that the genome projects provide analyses of the raw data to highlight potential genes of interest. Core bioinformatics support for the parasite genome projects has promoted these approaches. In the Brugia genome project, a combination of expressed sequence tag sequencing from multiple DNA libraries representing the complete filarial nematode lifecycle, and comparative analysis of the sequence dataset, particularly using the complete genome sequence of the model nematode C. elegans, has proved very effective in gene discovery.
-
[
Seminars in Developmental Biology,
1992]
The cell lineage of the nematode Caenorhabditis elegans is essentially invariant and many cell fates are autonomous. It seems likely that factors capable of influencing lineage-specific gene expressions are segregated or activated asymmetrically during the early cleavages. The maternal genome provides most of the raw materials for embryogenesis as well as the information required to pattern early cell divisions. Nonetheless, the zygotic genome is transcriptionally active early in embryogenesis and is expressing at least some genes required for future developmental decisions. Several of these zygotically active genes have been analysed; they show complex lineal expression patterns, implying that their regulation may not be as straightforward as initially thought. However, an understanding of the logic governing how different combinations of transcription factors regulate lineage-specific differentiation may be possible in this organism.
-
[
Phytomedicine,
2024]
BACKGROUND: Aging is the primary risk factor of most chronic diseases in humans, including cardiovascular diseases, osteoporosis and neurodegenerative diseases, which extensively damage the quality of life for elderly individuals. Aging is a multifaceted process with numerous factors affecting it. Efficient model organisms are essential for the research and development of anti-aging agents, particularly when investigating pharmacological mechanisms are needed. PURPOSE: This review discusses the application of Caenorhabditis elegans for studying aging and its related signaling pathways, and presents an overview of studies exploring the mechanism and screening of anti-aging agents in C. elegans. Additionally, the review summarizes related clinical trials of anti-aging agents to inspire the development of new medications. METHOD: Literature was searched, analyzed, and collected using PubMed, Web of Science, and Science Direct. The search terms used were "anti-aging", "medicinal plants", "synthetic compounds", "C. elegans", "signal pathway", etc. Several combinations of these keywords were used. Studies conducted in C. elegans or humans were included. Articles were excluded, if they were on studies conducted in silico or in vitro or could not offer effective data. RESULTS: Four compounds mainly derived through synthesis (metformin, rapamycin, nicotinamide mononucleotide, alpha-ketoglutarate) and four active ingredients chiefly obtained from plants (resveratrol, quercetin, Astragalus polysaccharide, ginsenosides) are introduced emphatically. These compounds and active ingredients exhibit potential anti-aging effects in preclinical and clinical studies. The screening of these anti-aging agents and the investigation of their pharmacological mechanisms can benefit from the use of C. elegans. CONCLUSION: Medicinal plants provide valuable resource for the treatment of diseases. A wide source of raw materials for the particular plant medicinal compounds having anti-aging effects meet diverse pharmaceutical requirements, such as immunomodulatory, anti-inflammation and alleviating oxidative stress. C. elegans possesses advantages in scientific research including short life cycle, small size, easy maintenance, genetic tractability and conserved biological processes related to aging. C. elegans can be used for the efficient and rapid evaluation of compounds with the potential to slow down aging.